A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Enterococci, one of the most common causes of hospital-associated infections, are responsible for substantial morbidity and mortality. Enterococcus faecalis, the more common and virulent species, causes serious high-inoculum infections, namely infective endocarditis, that are associated with cardiac surgery and mortality rates that remained unchanged for the last 30 years. The best cures for these infections are observed with combination antibiotic therapy; however, optimal treatment has not been fully elucidated. It is the purpose of this review to highlight treatment options and their limitations, and provide direction for future investigative efforts to aid in the treatment of these severe infections. While ampicillin plus ceftriaxone has emerged as a preferred treatment option, mortality rates continue to be high, and from a safety standpoint, ceftriaxone, unlike other cephalosporins, promotes colonization with vancomycin resistant-enterococci due to high biliary concentrations. More research is needed to improve patient outcomes from this high-mortality disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Antimicrobial‐Associated Risk Factors for Clostridium difficile Infection
Owens, Jr., Donskey, C. J., Gaynes, R. P., Loo, V. G., & Muto, C. A. (2008) · Clinical Infectious Diseases · doi:10.1086/521859 · Cited by 603
Fernández-Hidalgo, N., Almirante, B., Gavaldà, J., Gurgui, M., Peña, C., de Alarcón, A., Ruiz, J., Vilacosta, I., Montejo, M., Vallejo, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit052 · Cited by 311
Gavaldà, J., Len, O., Miró, J. M., Muñoz, P., Montejo, M., Alarcón, A., de la Torre-Cisneros, J., Peña, C., Martínez-Lacasa, X., Sarria, C., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00008 · Cited by 202
Gavaldà, J., Torres, C., Tenorio, C., López, P., Zaragoza, M., Capdevila, J. A., Almirante, B., Ruiz, F., Borrell, N., Gomis, X., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.639 · Cited by 134 · cited 1×
“faecalis endocarditis had lower bacterial vegetation counts than rabbits treated with ampicillin alone [9].”
BackgroundDahl, A., Rasmussen, R. V., Bundgaard, H., Hassager, C., Bruun, L. E., Lauridsen, T. K., Moser, C., Sogaard, P., Arpi, M., & Bruun, N. E. (2013) · Circulation · doi:10.1161/circulationaha.112.001170 · Cited by 108
Carugati, M., Bayer, A. S., Miró, J. M., Park, L. P., Guimarães, A. C., Skoutelis, A., Fortes, C. Q., Durante-Mangoni, E., Hannan, M. M., Nacinovich, F., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01563-13 · Cited by 100
Sakoulas, G., Nonejuie, P., Nizet, V., Pogliano, J., Crum-Cianflone, N., & Haddad, F. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02481-12 · Cited by 65 · cited 4×
“faecalis infections have been published [24, 26].”
BackgroundInfluentialMiro, J. M., Pericas, J. M., & del Rio, A. (2013) · Circulation · doi:10.1161/circulationaha.113.002431 · Cited by 46
Cited by
A Contemporary Picture of Enterococcal Endocarditis
Pericàs, J. M., Llopis, J., Muñoz, P., Gálvez-Acebal, J., Kestler, M., Valerio, M., Hernández-Meneses, M., Goenaga, M. Á., Cobo-Belaustegui, M., Montejo, M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.047 · Cited by 99
Metadata
- Authors
- Beganovic, M., Luther, M. K., Rice, L. B., Arias, C. A., Rybak, M. J., & LaPlante, K. L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-01-30
- Volume
- 67
- Issue
- 2
- Pages
- 303-309
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2790243014
- Cited by
- 234
- References
- 10
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.